Cancerogenic effect of different fragments of the hepatitis C virus core protein

European Journal of Cancer Prevention

Volumn 16, Issue 4, 2007, Pages 304-311

  Feng, Xiaoyan ^a   Zhang, Heqiu ^a   Liu, Hezhong ^a   Song, Xiaoguo ^a   Wang, Guohua ^a   Chen, Kun ^a   Ling, Shigan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cancerogenesis; Core protein (Core); Different fragments of core protein; Hepatitis C virus

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; HEPATITIS C CORE ANTIGEN[1-140]; HEPATITIS C CORE ANTIGEN[1-59]; HEPATITIS C CORE ANTIGEN[130-191]; HEPATITIS C CORE ANTIGEN[50-140]; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; MITOCHONDRION SWELLING; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; VIRUS CARCINOGENESIS;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENTAMICINS; HEPATITIS C; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SUBCELLULAR FRACTIONS; VIRAL CORE PROTEINS;

EID: 34547480273     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000236252.16855.82     Document Type: Article

References (36)

1. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, et al. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94:1200-1205.
2. Basu A, Meyer K, Ray RB, Ray R (2002). Hepatitis C virus protein is necessary for the maintenance of immortalized human hepatocytes. Virology 298:53-62.
3. Cai Q, Zhang X, Tian L, Yuan M, Jin G, Lu Z (2002). Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. J Med Virol 67:490-500.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
5. Chung YM, Park KJ, Choi SY, Hwang SB, Lee SY (2001). Hepatitis C virus core protein potentiates TNF-α- induced NF-κB activation through TRAF2-IKKβ-dependent pathway. Biochem Biophys Res Commun 284:15-19.
6. Dominguez-Malagon H, Gaytan-Graham S (2001). Hepatocellular carcinoma: an update. Ultrastruct Pathol 25:497-516.
7. Feng XY, Ling SG, Liu HZ, Zhang HQ, Song XG, Zhou T (2004). Subcellular localization of different truncated forms of hepatitis C virus core protein in HEK293 cells. Bull Acad Mil Med Sci 28:4-6, 15.
8. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K (1991). Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
9. Hope RG, McLauchlan J (2000). Sequence motif required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 81:1913-1925.
10. Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM (1998). Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem 273:17651-17659.
11. Inoue H, Seitz HK (2001). Viruses and alcohol in the pathogenesis of primary hepatic carcinoma. Eur J Cancer Prev 10:107-110.
12. Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, et al. (2000). Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J 19:729-740.
13. Kao CF, Chen SY, Chen JY, Wu Lee YH (2004). Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23:2472-2483.
14. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS (2000). Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106:1239-1249.
15. Kondo F, Wada K, Nagato Y, Nakajima T, Kondo Y, Hirooka N, et al. (1989). Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 9:751-755.
16. Kurokohchi K, Arima K, Nishioka M (2001). A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection. J Hepatol 34:930-935.
17. Lagging LM, Meyer K, Hoft H, Houghton M, Belshe RB, Ray R (1995). Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 69:5859-5863.
18. Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH (1999). Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264:134-141.
19. Mamiya N, Worman HJ (1999). Hepatitis C virus core protein binds to a DEAD box RNA helicase. J Biol Chem 274:15751-15756.
20. Matsumoto M, Hwang SB, Jeng KS, Zhu N, Lai MM (1996). Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218:43-51.
21. McLauchlan J (2000). Properties of the hepatitis C virus protein: a structural protein that modulates cellular processes. J Viral Hepatitis 7:2-14.
22. Nolandt O, Kern V, Muller H, Pfaff E, Theilmann L, Welker R, Krausslich HG (1997). Analysis of hepatitis C virus core protein interaction domains. J Gen Virol 78:1331-1340.
23. Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, et al. (2000). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275:34122-34130.
24. Owsianka AM, Patel AH (1999). Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257:330-340.
25. Rapaccini GL, Pompili M, Caturelli E, Fasilli S, Trombino C, Gomes V, et al. (1994). Ultrasound-guided fine-needle biopsy of hepatocellular carcinoma: comparison between smear cytology and microhistology. Am J Gastroenterol 89:898-902.
26. Ray RB, Lagging LM, Meyer K, Ray R (1996). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70:4438-4443.
27. Realdon S, Gerotto M, Pero FD, Marin O, Granato A, Basso G, et al. (2004). Proapoptotic effect of hepatitis C virus Core protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation. J Hepat 40:77-85.
28. Suzuki R, Matsuura Y, Suzuki T, Ando A, Chiba J, Harada S, et al. (1995). Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 76:53-61.
29. Takao Y, Yamada A, Yutani S, Sata M, Itoh K (2004). Antibody reactive to a hepatitis C virus (HCV)-derived capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction. Microbiol Immunol 48:507-517.
30. Takayuki Y, Masao U, Takefumi D (2002a). Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun 294:521-527.
31. Takayuki Y, Tatsuhiko K, Takafumi D (2002b). Subcellular localization of HCV core regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun 294:528-534.
32. Takenaka A, Kaji I, Kasugi H, Sasaki Y, Ishiguro S, Wada A, et al. (1999). Usefulness of diagnostic criteria for aspiration cytology of hepatocellular carcinoma. Acta Cytol 43:610-616.
33. Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C (2001). Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology 33:1533-1543.
34. Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS (2004). Direct binding of hepatitis C virus core to gC1qR on CD4 + and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol 78:6409-6419.
35. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MM (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor1 and enhances TNF-induced apoptosis. J Virol 72:3691-3697.
36. Zhu N, Ware CF, Lai MMC (2001). Hepatitis C virus protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 283:178-187.